IMMUNOREGULATION OF MYELOMA CELL DIFFERENTIATION
IMMUNOREGULATION OF MYELOMA CELL DIFFERENTIATION
批准号:
3168293
负责人:
JAMES W ROHRER
金额:
$8.78万
依托单位国家:
美国
项目类别:
财政年份:
1980
资助国家:
美国
项目状态:
已结题
起止时间:
1980-07-01 至 1987-02-28
关键词:
B lymphocyte T lymphocyte antibody formation autoradiography cell differentiation cellular immunity cellular oncology cyclic nucleoside monophosphate gene expression helper T lymphocyte hybridomas immune adherence reaction immunoglobulin A immunoglobulin G immunoglobulin genes immunologic memory immunoregulation leukocyte activation /transformation leukocyte activation disorder lymphokines major histocompatibility complex membrane permeability monoclonal antibody myeloma globulin neoplasm /cancer immunology neoplasm /cancer immunotherapy neoplasm /cancer transplantation neoplastic growth plaque assay radioimmunoassay radiotracer suppressor T lymphocyte surface antigens
中文摘要
B淋巴细胞对抗原的反应是通过增殖和分化为
分泌抗体的浆细胞。这种反应可以增强或抑制
通过抗原特异性T辅助细胞(TH)或T抑制细胞(TS),
分别进行了分析。分泌TNP特异性IgA315的骨髓瘤MOPC-315血浆
细胞是由恶性的无分泌性小细胞分化而来的
淋巴样干细胞。成纤维细胞的增殖和分化
干细胞可以由不同的携带者特异性TH和TH亚群调节
TS细胞。我对确定其中涉及的生化变化很感兴趣
激活和抑制MOPC-315细胞的分泌分化。
直到纯化的辅助因子和抑制因子可从
我的单克隆性分化辅助和抑制T细胞系
研究;(1)MOPC-315分化是否受
胸腺非依赖性抗原TNP-LPS(E.Coli055:B5脂多糖),
以及(2)这种调节的某些代谢需求是什么。
我发现,虽然未结合或FITC结合的内毒素对315细胞没有影响
当添加剂量低于10微克/毫升时,细胞分化
在体外,观察到315细胞的PFC频率显著增加
0.001-0.1微克/mlTNP-内毒素对315细胞的明显抑制作用
1.0微克/mlTNP-内毒素可诱导产生抗TNP-IgA PFC频率。这些
如果抗独特型315的单抗或
培养基中含有DNP-甘氨酸,表明TNP-内毒素
需要结合表面膜IgA315。刺激性剂量
只需在最初的2小时内存在即可达到最大
在培养开始48小时后测量增强。抑制剂量
TNP-LPS必须存在24小时才能最大限度地抑制PFC
辅助性T细胞刺激的频率和最大无反应性
分泌分化。这种曾经引起的无反应持续了5-7天
几天。在培养的第一个小时内,用刺激量
TNP-LPS,PFC所需的丝氨酸酯酶被激活
频率增强。这种丝氨酸酯酶活性需要磷脂
在TNP-LPS孵育的前15分钟内诱导甲基化。
抑制剂量的TNP-内毒素不会引起这些变化,但会改变
315细胞代谢使后续培养浓度为0.01微克/毫升
TNP-内毒素不增加PFC频率和丝氨酸酯酶和
磷脂甲基化不会发生。我正在继续这些研究,并且
AM开始确定细胞核、细胞质和
膜蛋白的二维凝胶电泳法磷酸化。(磅)
英文摘要
B lymphocytes respond to antigen by proliferating and differentiating into
antibody-secreting plasmacytes. That response can be enhanced or inhibited
by antigen-specific T-helper (TH) or T-suppressor (TS) cells,
respectively. The TNP-specific IgA315-secreting MOPC-315 myeloma plasma
cells arise by differentiation from malignant small, nonsecretory
lymphocytoid stem cells. The proliferation and differentiation of those
stem cells can be regulated by distinct subsets of carrier-specific TH and
TS cells. I was interested in determining the biochemical changes involved
in activation and suppression of MOPC-315 cell secretory differentiation.
Until purified helper and suppressor regulatory factors were available from
my monoclonal differentiation helper and suppressor T-cell lines, I
investigated; (1) whether MOPC-315 differentiation could be modulated by
the thymus-independent antigen TNP-LPS (E. coli 055:B5 lipopolysaccharide),
and (2) what some of the metabolic requirements were for that modulation.
I found that while unconjugated or FITC-conjugated LPS had no effect on 315
cell differentiation when added at doses lower than 10 micrograms/ml in
vitro, significant enhancement of 315 cell PFC frequency was observed with
from 0.001-0.1 micrograms/ml TNP-LPS and significant inhibition of 315 cell
anti-TNP IgA PFC frequency was induced at 1.0 micrograms/ml TNP-LPS. These
low dose effects were blocked if monoclonal anti-idiotype315 antibody or
DNP-glycine were included in the culture media implying that TNP-LPS
engagement of surface membrane IgA315 was required. The stimulatory dose
of TNP-LPS had to be present for only the first 2 hrs to get maximal
enhancement measured 48 hrs after culture initiation. The inhibitory dose
of TNP-LPS had to be present 24 hrs to get maximal inhibition of PFC
frequency and maximal unresponsiveness to helper T-cell stimulation of
secretory differentiation. This unresponsiveness once induced lasted 5-7
days. Within the first 1 hr of culture with the stimulatory dose of
TNP-LPS, a serine esterase is activated which is required for the PFC
frequency enhancement. This serine esterase activity requires phospholipid
methylation within the first 15 min of TNP-LPS incubation to be induced.
The inhibitory dose of TNP-LPS does not induce these changes but alters the
315 cell metabolism such that subsequent culture with 0.01 micrograms/ml
TNP-LPS does not enhance PFC frequency and the serine esterase and
phospholipid methylation does not occur. I am continuing these studies and
am beginning to determine temporal changes in nuclear, cytoplasmic, and
membrane protein phosphorylation using 2D gel electrophoresis. (LB)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MONOCLONAL T LYMPHOCYTE FACTOR REGULATION OF MYELOMA
-
批准号:3173251
-
项目类别:
-
资助金额:$12.81万
-
财政年份:1984
-
负责人:JAMES W ROHRER
-
依托单位:
MONOCLONAL T LYMPHOCYTE FACTOR REGULATION OF MYELOMA
-
批准号:3173249
-
项目类别:
-
资助金额:$9.33万
-
财政年份:1984
-
负责人:JAMES W ROHRER
-
依托单位:
MONOCLONAL T LYMPHOCYTE FACTOR REGULATION OF MYELOMA
-
批准号:3173250
-
项目类别:
-
资助金额:$9.49万
-
财政年份:1984
-
负责人:JAMES W ROHRER
-
依托单位:
MONOCLONAL T LYMPHOCYTE FACTOR REGULATION OF MYELOMA
-
批准号:3173247
-
项目类别:
-
资助金额:$13.59万
-
财政年份:1984
-
负责人:JAMES W ROHRER
-
依托单位:
MONOCLONAL T LYMPHOCYTE FACTOR REGULATION OF MYELOMA
-
批准号:3173252
-
项目类别:
-
资助金额:$13.01万
-
财政年份:1984
-
负责人:JAMES W ROHRER
-
依托单位:
IMMUNOREGULATION OF MYELOMA CELL DIFFERENTIATION
-
批准号:3168294
-
项目类别:
-
资助金额:$8.94万
-
财政年份:1980
-
负责人:JAMES W ROHRER
-
依托单位:
海外基金